Table 2.
Clinical features of the analyzed setting of ovarian cancer patients
| Characteristics | CU* clinical setting | TCGA |
|---|---|---|
| Cases | 346 | 344 |
| Age, yrs | ||
| Median (range) | 60 (24-84) | 58 (30-87) |
| FIGO Stage (%) | ||
| I-II | 12 (3.5) | 19 (5.6) |
| III | 271 (78.3) | 276 (80.2) |
| IV | 63 (18.2) | 49 (14.2) |
| Histotype (%) | ||
| Papillary-serous | 346 (100) | 344 (100) |
| Ca 125 | ||
| Median (range) | 683 U/mL (6->10,000) | N.A |
| Status (%) | ||
| Dead | 232 (67.0) | 190 (59.6) |
| Alive | 114 (33.0) | 156 (40.4) |
| Median follow up (Alive) | 68 months | onths |
*
Catholic University clinical setting.